MXPA03010601A - Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. - Google Patents
Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos.Info
- Publication number
- MXPA03010601A MXPA03010601A MXPA03010601A MXPA03010601A MXPA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A MX PA03010601 A MXPA03010601 A MX PA03010601A
- Authority
- MX
- Mexico
- Prior art keywords
- methylamine
- derivatives
- medicament
- thiophen
- furan
- Prior art date
Links
- DDRPCXLAQZKBJP-UHFFFAOYSA-N furfurylamine Chemical class NCC1=CC=CO1 DDRPCXLAQZKBJP-UHFFFAOYSA-N 0.000 title abstract 2
- FKKJJPMGAWGYPN-UHFFFAOYSA-N thiophen-2-ylmethanamine Chemical class NCC1=CC=CS1 FKKJJPMGAWGYPN-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 6
- 229940079593 drug Drugs 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000003251 Pruritus Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 229940035676 analgesics Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940125683 antiemetic agent Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002664 nootropic agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10125145A DE10125145A1 (de) | 2001-05-22 | 2001-05-22 | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
| PCT/EP2002/005542 WO2002094802A1 (de) | 2001-05-22 | 2002-05-21 | Substituierte c-furan-2-yl-methylamin- und c-thiophen-2-yl-methylamin-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03010601A true MXPA03010601A (es) | 2004-03-09 |
Family
ID=7685874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03010601A MXPA03010601A (es) | 2001-05-22 | 2002-05-21 | Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6878740B2 (https=) |
| EP (1) | EP1392670B1 (https=) |
| JP (1) | JP2004532246A (https=) |
| AR (1) | AR035982A1 (https=) |
| AT (1) | ATE299873T1 (https=) |
| AU (1) | AU2002338989B2 (https=) |
| CA (1) | CA2448038C (https=) |
| DE (2) | DE10125145A1 (https=) |
| DK (1) | DK1392670T3 (https=) |
| ES (1) | ES2242869T3 (https=) |
| HU (1) | HUP0401162A3 (https=) |
| MX (1) | MXPA03010601A (https=) |
| PE (1) | PE20021099A1 (https=) |
| PL (1) | PL367535A1 (https=) |
| PT (1) | PT1392670E (https=) |
| SI (1) | SI1392670T1 (https=) |
| WO (1) | WO2002094802A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0302094D0 (en) | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| GB0324269D0 (en) * | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| KR100553398B1 (ko) * | 2004-03-12 | 2006-02-16 | 한미약품 주식회사 | 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체 |
| CN102482249B (zh) | 2009-07-08 | 2016-06-08 | 德米拉(加拿大)公司 | 用于治疗皮肤病症或疾病状态的tofa类似物 |
| KR20160101928A (ko) * | 2013-11-22 | 2016-08-26 | 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 | 흡입 약제 |
| KR101844984B1 (ko) * | 2016-05-31 | 2018-04-03 | 한림대학교 산학협력단 | 5원 헤테로사이클릭 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| CN112521357B (zh) * | 2020-08-31 | 2021-10-08 | 深圳瑞健生物科技有限公司 | 一种长效低成瘾性hnk衍生物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3816457A (en) * | 1973-01-05 | 1974-06-11 | Richardson Merrell Inc | Lactamimide derivatives |
| US3890445A (en) * | 1973-01-05 | 1975-06-17 | Richardson Merrell Inc | Lactamimide derivatives useful as hypoglycemic agents |
| WO2001068816A1 (en) | 2000-03-13 | 2001-09-20 | Smithkline Beecham Corporation | Human histamine h3 gene variant-3 |
| DE10012820A1 (de) * | 2000-03-16 | 2001-09-20 | Bayer Ag | Substituierte 1-Aryl-cyclopropylmethylamino-1,3,5-triazine |
| DE10059864A1 (de) * | 2000-11-30 | 2002-06-13 | Gruenenthal Gmbh | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
-
2001
- 2001-05-22 DE DE10125145A patent/DE10125145A1/de not_active Withdrawn
-
2002
- 2002-05-17 AR ARP020101843A patent/AR035982A1/es not_active Application Discontinuation
- 2002-05-21 JP JP2002591475A patent/JP2004532246A/ja active Pending
- 2002-05-21 DE DE50203686T patent/DE50203686D1/de not_active Expired - Lifetime
- 2002-05-21 EP EP02743057A patent/EP1392670B1/de not_active Expired - Lifetime
- 2002-05-21 MX MXPA03010601A patent/MXPA03010601A/es active IP Right Grant
- 2002-05-21 DK DK02743057T patent/DK1392670T3/da active
- 2002-05-21 PE PE2002000428A patent/PE20021099A1/es not_active Application Discontinuation
- 2002-05-21 PT PT02743057T patent/PT1392670E/pt unknown
- 2002-05-21 AU AU2002338989A patent/AU2002338989B2/en not_active Ceased
- 2002-05-21 PL PL02367535A patent/PL367535A1/xx not_active Application Discontinuation
- 2002-05-21 SI SI200230178T patent/SI1392670T1/sl unknown
- 2002-05-21 WO PCT/EP2002/005542 patent/WO2002094802A1/de not_active Ceased
- 2002-05-21 CA CA2448038A patent/CA2448038C/en not_active Expired - Fee Related
- 2002-05-21 HU HU0401162A patent/HUP0401162A3/hu unknown
- 2002-05-21 AT AT02743057T patent/ATE299873T1/de not_active IP Right Cessation
- 2002-05-21 ES ES02743057T patent/ES2242869T3/es not_active Expired - Lifetime
-
2003
- 2003-11-21 US US10/717,932 patent/US6878740B2/en not_active Expired - Fee Related
-
2005
- 2005-03-07 US US11/072,962 patent/US7317034B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1392670B1 (de) | 2005-07-20 |
| PE20021099A1 (es) | 2003-01-25 |
| CA2448038C (en) | 2010-09-28 |
| HUP0401162A2 (hu) | 2004-10-28 |
| AU2002338989B2 (en) | 2007-06-07 |
| CA2448038A1 (en) | 2002-11-28 |
| US6878740B2 (en) | 2005-04-12 |
| PL367535A1 (en) | 2005-02-21 |
| ES2242869T3 (es) | 2005-11-16 |
| ATE299873T1 (de) | 2005-08-15 |
| DE10125145A1 (de) | 2002-11-28 |
| PT1392670E (pt) | 2005-10-31 |
| HUP0401162A3 (en) | 2007-05-02 |
| EP1392670A1 (de) | 2004-03-03 |
| US20040152734A1 (en) | 2004-08-05 |
| JP2004532246A (ja) | 2004-10-21 |
| US20050148550A1 (en) | 2005-07-07 |
| WO2002094802A1 (de) | 2002-11-28 |
| DE50203686D1 (en) | 2005-08-25 |
| DK1392670T3 (da) | 2005-08-08 |
| SI1392670T1 (sl) | 2005-12-31 |
| US7317034B2 (en) | 2008-01-08 |
| AR035982A1 (es) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2088A (en) | Phenethanolamine derivatives for treatment of respiratory diseases | |
| MY129422A (en) | Medicinal compounds | |
| WO2004037768A3 (en) | Phenethanolamine derivatives | |
| UA74346C2 (uk) | Похідні амінодикарбонових кислот, їх застосування та лікарський засіб | |
| WO2004037807A3 (en) | Medicinal arylethanolamine compounds | |
| WO2002070510A3 (de) | Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| GEP20043269B (en) | Purine Derivatives, Method for Their Production and Composition Containing the Same | |
| SG167657A1 (en) | Novel medicament compositions based on tiotropium salts and on salmeterol salts | |
| WO2001085212A3 (en) | Drug delivery systems for photodynamic therapy | |
| ATE365720T1 (de) | Agonisten von beta-adrenorezeptoren | |
| IL159257A0 (en) | Substituted oxazolidinones for combinational therapy | |
| WO2001019776A3 (de) | Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| HRP20040944B1 (en) | Medicaments containing betamimetic drugs and a novel anticholinesterase drug | |
| WO2004026306A3 (en) | Pyrazole derivatives as transforming growth factor (tgf) inhibitors | |
| WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| BR0209276A (pt) | Uso da azitromicina para a preparação de um medicamento para tratamento de doenças inflamatórias não infecciosas | |
| WO2003087049A3 (de) | Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum | |
| WO2001024783A3 (de) | Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| MXPA03010601A (es) | Derivados de c-furan-2-il-metilamina y c-tiofen-2-il-metilamina sustituidos. | |
| BR0210473A (pt) | Composição compreendendo um inibidor da pde-4 e antagonista do receptor-h1 e seus usos na produção de um medicamento para o tratamento de doenças respiratórias | |
| CA2433833A1 (en) | Use of flumazenil in developing a drug for the treatment of alcohol dependence | |
| EP1249247A3 (en) | Pharmaceutical preparation for the treatment of gynecological diseases | |
| MX9800620A (es) | (r)-5-bromo-n-(1-etil-4-metilhexahidro-1h-1,4-diazepin-6-il- 2-metoxi-6-metilamino-3-piridincarboxamida, proceso para preparacion del mismo y composicion farmaceutica que contiene tal compuesto. | |
| WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |